Ben Tre Pharmaceutical JSC

Ben Tre Pharmaceutical JSC EBITDA per Employee

The EBITDA per Employee of Ben Tre Pharmaceutical JSC (DBT.VN) as of Oct 30, 2026 is 88.80 M VND. In the previous year, EBITDA per Employee was 106.57 M VND — a change of -16.67% (lower).

EBITDA per Employee

88.80 MVND

YoY

-16.67%

Last updated:

EBITDA per Employee of Ben Tre Pharmaceutical JSC is 2024 88.80 M VND. EBITDA per Employee of Ben Tre Pharmaceutical JSC was 2023 106.57 M VND. It decreases by -16.67% lower compared to the previous year.

The Ben Tre Pharmaceutical JSC EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2014
20.54 M VND
Jan 1, 2015
9.16 M VND
Jan 1, 2020
49.20 M VND
Jan 1, 2021
21.53 M VND
Jan 1, 2022
56.35 M VND
Jan 1, 2023
106.57 M VND
Jan 1, 2024
88.80 M VND
The Ben Tre Pharmaceutical JSC EBITDA per Employee history
YEAREBITDA per EmployeeYoY
88.80 MVND-16.67%
106.57 MVND+89.12%
56.35 MVND+161.69%
21.53 MVND-56.23%
49.20 MVND+437.36%
9.16 MVND-55.42%
20.54 MVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ben Tre Pharmaceutical JSC Stock analysis

What does Ben Tre Pharmaceutical JSC do? Ben Tre Pharmaceutical JSC manufactures and distributes pharmaceutical products, including medicinal products through its subsidiaries. The company wholesales, imports, and exports pharmaceuticals, materials, chemicals, packagings, and biological products. It also retails drugs and trades supplements, medical equipment, supplies, and machinery. The firm rents commercial space for additional revenue. Its primary customers are healthcare providers, pharmacies, and medical institutions requiring pharmaceuticals and medical supplies. The company's revenue streams include pharmaceutical manufacturing, wholesale distribution, import/export services, retail drug sales, and commercial space rentals. Key segments are pharmaceuticals, medical equipment, and biological products. The firm serves healthcare sectors through its subsidiaries and direct retail channels. Revenue is generated from both domestic and international trade activities. Ben Tre Pharmaceutical JSC's products include pharmaceuticals, medicinal products, medical equipment, and supplements. The company's brands are not specified in the business description. It targets healthcare providers, pharmacies, and medical institutions as its main buyers. The firm's operations span manufacturing, distribution, retail, and commercial leasing within the pharmaceutical and medical sectors. Ben Tre Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ben Tre Pharmaceutical JSC stock

EBITDA per Employee of Ben Tre Pharmaceutical JSC is 88.80 M VND in 2024.

EBITDA per Employee of Ben Tre Pharmaceutical JSC changed from 106.57 M VND to 88.80 M VND, representing a -16.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Ben Tre Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Ben Tre Pharmaceutical JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Ben Tre Pharmaceutical JSC

All Key Metrics — Ben Tre Pharmaceutical JSC